Harish Shantharam, Cfa
About Harish Shantharam, Cfa
Harish Shantharam Chief Financial Officer
Harish Shantharam currently serves as the Chief Financial Officer. His role involves overseeing all financial operations and strategies, ensuring fiscal responsibility, and facilitating long-term financial planning. As a CFO, Harish is responsible for managing financial risks, preparing financial statements, and providing strategic financial guidance to the company’s executive team.
Harish Shantharam Education and Credentials
Harish Shantharam holds an MBA in Finance from UCLA Anderson School of Management, which equipped him with advanced financial knowledge and leadership skills. He also graduated with a degree in Industrial Engineering from the University of Texas, Arlington. Further solidifying his expertise, Harish is a CFA charter holder, demonstrating his in-depth knowledge of investment management and financial analysis.
Harish Shantharam Eikon Therapeutics
Since August 2022, Harish Shantharam has been serving as a Senior Finance Advisor at Eikon Therapeutics. In this position, he provides expert financial advice, assists in budgeting, and offers strategic insights to support the company’s financial health. His role involves collaborating with other senior leaders to align financial strategies with the company's objectives.
Harish Shantharam Gilead Sciences
Harish Shantharam held several senior financial leadership roles at Gilead Sciences, including Vice President of Global Commercial Finance. In this capacity, he supported a $20-30 billion revenue business across multiple regions including North America, Europe, Asia, and emerging markets. His responsibilities encompassed financial forecasting, commercial analytics, and business development, contributing significantly to Gilead’s financial strategies.
Harish Shantharam Experience at Amgen
At Amgen, Harish Shantharam served in various roles supporting forecasting, commercial analytics, and business development. His work involved analyzing market trends, preparing financial forecasts, and providing analytical support for business development initiatives. This experience honed his skills in financial analysis and strategic planning, contributing to his extensive background in the biopharmaceutical industry.